Skip to main navigation
Skip to search
Skip to main content
University of Luebeck Home
English
Deutsch
Home
Research Units
Experts
Publications
Projects
Prizes
Spin-Offs
Activities
Media
Search by expertise, name or affiliation
Intravenous pulse cyclophosphamide in the treatment of interstitial lung disease due to collagen vascular diseases
Armin Schnabel
*
, Michael Reuter, Wolfgang L. Gross
*
Corresponding author for this work
Clinic of Rheumatology
University of Kiel
143
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Intravenous pulse cyclophosphamide in the treatment of interstitial lung disease due to collagen vascular diseases'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Treatment of Interstitial Lung Disease
100%
Patient
80%
Lung Lavage
60%
High-Resolution Computed Tomography
40%
Evaluation
20%
Lung
20%
Spontaneous Remission
20%
Cyclosporine
20%
Sjoegren Syndrome
20%
Immunology and Microbiology
Lung
100%
Neutrophil
20%
Systemic Scleroderma
20%
Sjögren's Syndrome
20%
Maintenance Drug Dose
20%
Systemic Lupus Erythematosus
20%
Ciclosporin
20%
Attenuation
20%
Prednisolone
20%
Surface Area
20%
Body Surface
20%
Polymyositis
20%
Pharmacology, Toxicology and Pharmaceutical Science
Systemic Sclerosis
20%
Remission
20%